EVP, Chief Financial Officer Lakkaraju Roop Kalyan converted options into 1,535 units of Bio-Rad A Common Stock and covered exercise/tax liability with 550 units of Bio-Rad A Common Stock, increasing direct ownership by 115% to 1,844 units (SEC Form 4)